Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.
Immutrin is a biotech developing next‑generation antibody therapies to clear amyloid deposits and reverse amyloidosis.
Candid Therapeutics develops therapies for autoimmune diseases using antibody-based technologies that modulate immune system activity.
Gemsouls is an AI technology that powers virtual characters and their interactions with the real world.
Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
CODE 27 develops software solutions focused on digital platforms, data systems, and custom technology applications.
Video Rebirth is a private limited company that is established with shares.
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
HashQuark is a staking and blockchain infrastructure services provider that is secure, stable, and convenient.
Theraheart is a medical device company that offers innovative, minimally invasive solutions for heart failure.
Fasikl is a neuro-AI company that creates interfaces for the nervous system.
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
Rhino Federated Computing provides a platform for AI collaboration enterprises to accelerate data strategies and to expand AI use cases.
Soda Health is a healthcare technology company dedicated to eliminating health inequities through social determinants of health.
Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.
The Clique Compute Coordination Network organizes various heterogeneous compute resources & allocates them efficiently to applications.
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
DeBank creates a cryptocurrency wallet that allows users to access decentralized finance services.
Complete Omics is a developer of multi-omics diagnostics for early disease detection.
Manta Network is building a secure and interoperable future with Zero-Knowledge.
NFTGo is a NFT data aggregator where users can find information about NFT.
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.
Qiming Venture Partners has invested in 399 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Qiming Venture Partners's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Medical, Artificial Intelligence (AI). The firm invests across 29 different industry categories.
Among tracked funding rounds, Candid Therapeutics received $505.0M in a Undisclosed round. Qiming Venture Partners's total known invested capital is $14.9B.
Qiming Venture Partners's average investment size is $60.5M across its portfolio of 399 companies.
Recent Qiming Venture Partners portfolio additions include Vor Biopharma, Pinnacle Medicines, Immutrin, Candid Therapeutics, Gemsouls. These companies were founded in 2020 or later.